CeNeS Pharmaceuticals plc

CeNeS is granted patent for short-acting sedatives

Published in Medicine and Law Weekly, March 17th, 2006

CeNeS Pharmaceuticals plc (CEN) reported that a key patent on its short-acting sedatives has been granted by the European Patent Office (EPO).

The patent covers a series of sedative compounds, including CNS 7056X, which is in preclinical development. The EPO is the first to grant the patent. National applications are pending in other key territories including the USA and Japan. The patent application, (No 00930686.1, publication number 1183243) was assigned to CeNeS from GlaxoSmithKline in November 2003.

CeNeS' short-acting sedatives are being developed for use in patients undergoing short diagnostic and surgical procedures. CNS 7056X is CeNeS' lead...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2006-03-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry